Uitgebreid zoeken

Momenteel bekleedt Avinash Rugoobur de functie van President & Director bij Arrival Group SA. Hij is tevens lid van de raad van bestuur van Arrival Ltd.

Avinash Nangia is Senior Vice President of Research and Development for Spherics, Inc. and a Member of the American Association of Pharmaceutical Scientists, The Controlled Release Society and the American College of Clinical Pharmacology.
Prior to joining Spherics he was Director of Research and Development for Andrx Corp., Research Fellow and Manager of the Oral Product Development Group and Group Leader of Pharmaceutical Research and Senior Research Scientist for Intramural Basic Research.
He held various positions at Alza Corp., Glaxo Canada, Inc. and Andrx Pharmaceuticals, Inc. Dr. Nangia received a PhD in Pharmaceutics from the University of Otago, an MS degree in Pharmaceutics from Banaras Hindu University and a BS degree in Pharmacy from the University of Delhi, India.

Mr. Avinash Vazirani is an Investment Manager at Jupiter Asset Management Ltd.
He is on the Board of Directors at UK India Business Council.
He joined Jupiter in 2007 and is in the Indian Equities team.
Before joining Jupiter, Mr. Vazirani was Chief Investment Officer (South Asia and Africa) of BNP Paribas Asset Management.
He later founded Peninsular Capital Partners LLP in 2005, where he was managing partner.
He was also the Chief Executive Officer of GEM Dolphin Investment Managers from 1994 until its sale in 1997.
He is a qualified Chartered Accountant.